For years, International Business Machines was written off as a tech relic, a company that had missed the cloud revolution. But a relentless pivot toward artificial intelligence — and the physical infrastructure to support it — has recast the narrative. Now, with two major product launches and a quarterly earnings report days away, the market is watching whether this industrial-scale bet can convert a $12.5bn AI order backlog into genuine revenue acceleration.
The stock has already priced in a great deal of optimism. Shares closed Wednesday at €264.35, up nearly 10% in the past month and a staggering 46% above the 52-week low of roughly €181 set in May. The current price stands 17% above its 50-day moving average, a level that often signals momentum. Yet the Relative Strength Index has climbed to 66, nudging toward overbought territory — a technical reminder that the rally may be getting stretched.
That tension between enthusiasm and caution will be put to the test on July 22, when IBM opens its books for the second quarter. Analysts at Bank of America have already raised their price target, and some believe management could lift its full-year guidance. The broader consensus sits near €257, well below where the stock actually trades, suggesting a wave of analyst upgrades may be imminent.
Lightwell and the $5bn Security Wager
Underpinning IBM’s renewed credibility is a massive bet on trust infrastructure — a term the company uses to describe secure, enterprise-grade AI deployment. The centerpiece of that effort is “Lightwell,” a platform developed jointly with its Red Hat subsidiary and unveiled Wednesday.
Lightwell uses generative AI to automatically detect and patch vulnerabilities in open-source code, a task that has become a nightmare for IT departments reliant on languages like Java and Python. The platform ships with a network of more than 6,500 digitally signed software components for developers, alongside a dedicated program for the financial sector. IBM has lined up Microsoft, Intel, Amazon Web Services and Nvidia as launch partners.
Should investors sell immediately? Or is it worth buying IBM?
The development cost: approximately $5bn and the work of roughly 20,000 engineers. The payoff, IBM hopes, is a lock on the security layer that makes enterprise AI possible — especially in heavily regulated industries where data leaks are the single biggest barrier to adoption.
Mainframes Make a Comeback
At the same time, IBM is doubling down on its oldest strength: the mainframe. On August 12, the company will launch the z17 and LinuxONE 5 systems, compact enough to fit into standard data-center racks. Each machine packs up to 82 processor cores and 18 terabytes of memory, processing 450 billion AI queries per day. The new z17 chip alone delivers 50% more AI operations than its predecessor.
The timing is deliberate. Data centers are running out of space and power, and hyperscale operators are desperate for more compute density. IBM is positioning its refreshed mainframe line as the ultimate space-saving, power-efficient solution for inference workloads — a role the mainframe never played in the cloud era.
What the Earnings Call Must Prove
The real question is how much of this infrastructure push is already translating into revenue. By the end of 2025, IBM’s generative AI order book stood at more than $12.5bn. When management reports second-quarter results on July 22, investors will be looking for concrete evidence that those contracts are moving from backlog to billings.
If the numbers confirm the momentum, IBM will cement its transformation from a dinosaur into the essential foundation layer of the AI economy. If they fall short, a stock that has rallied hard — and is now technically extended — could face a sharp reset. Either way, the next few weeks will determine whether the market’s new faith in Big Blue is built on more than a fast-climbing RSI.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from July 9 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 9.
IBM: Buy or sell? Read more here...










